Another mutually nonexclusive possibility for the mild course of COVID‐19 in children could be a lower expression of the angiotensin‐converting enzyme 2 (ACE2) receptor, which is recognized by the receptor‐binding domain (RBD) of SARS‐CoV‐2.12, 13, 14, 15. The gene discussed is ACE2; the disease is COVID-19.